asenapine has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maina, G; Ripellino, C | 1 |
| Potkin, SG | 1 |
1 review(s) available for asenapine and Dyslipidemia
| Article | Year |
|---|---|
Asenapine: a clinical overview.
Topics: Antipsychotic Agents; Blood Glucose; Dibenzocycloheptenes; Dyslipidemias; Heterocyclic Compounds, 4 or More Rings; Humans; Schizophrenia; Treatment Outcome; Weight Gain | 2011 |
1 other study(ies) available for asenapine and Dyslipidemia
| Article | Year |
|---|---|
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Diabetes Mellitus, Type 2; Dibenzocycloheptenes; Dyslipidemias; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Italy; Male; Mental Disorders; Middle Aged; Olanzapine; Retrospective Studies; Spain | 2014 |